LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.
Shilan LiuXiao LiuQinghui YangChunhua ZengGang HuBochen RenPublished in: The Journal of pharmacy and pharmacology (2024)
Our findings illuminated the molecular mechanism of LINC01572 influencing LUAD and provided new insights for targeted therapy of LUAD cells.